Takeda Highlights Favorable Safety Profile of EntyvioR vedolizumab Through Comparative RealWorld Data Versus TNFAntagonist Therapy in Ulcerative Colitis and Crohn's Disease

OSAKA Japan June 4 2018 PRNewswire Takeda demonstrates leadership in GI by featuring new U.S. VICTORY Consortium data among its 24 sponsored Entyvio abstracts presented at the Digestive Disease Week DDW 2018 meeting Takeda Pharmaceutical Company Limited ...